Other substances

Kasugamycin

An aminoglycoside antibiotic.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
1
 Clinical trials

General information

Kasugamycin is an aminoglycoside antibiotic with antifungal properties (ChEBI).

Kasugamycin on PubChem
Kasugamycin on Wikipedia

Synonyms

Ksg; Kasumin L

 

Structure image - Kasugamycin

C[C@@H]1[C@H](C[C@@H]([C@H](O1)OC2[C@@H]([C@H](C([C@@H]([C@@H]2O)O)O)O)O)N)N=C(C(=O)O)N


 

Supporting references

Link Tested on Impact factor Notes Publication date
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
Small molecule In vitro 		in vitro bacteria-based assay 3.82

Displayed inhibitory activity against the potential ion channel ORF3a of SARS-CoV-2 in a bacterial model assay.

 Mar/23/2021

AI-suggested references

Link Publication date
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19
Nov/08/2021

Clinical trials

ID Title Status Phase Start date Completion date
NCT04644328 The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign Completed Not Applicable Nov/12/2020 Feb/11/2021
  • Alternative id - 2003000118A010
  • Interventions - Behavioral: Facebook Ads on the importance of staying safe during the Thanksgiving / Christmas holiday
  • Study type - Interventional
  • Study results - Has Results
  • Locations - JPAL North America, Cambridge, Massachusetts, United States
  • Study designs - Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Prevention
  • Enrollment - 820
  • Age - 18 Years and older   (Adult, Older Adult)
  • Outcome measures - Facebook Movement Metric|Percentage Leaving Home on Day of Holiday|Inverse Hyperbolic Sine of COVID-19 Cases|Knowledge of COVID-19 Prevention Message (Recall of ad, Intent to Travel, Mask Wearing and Beliefs About Travel)|Average Number of Tiles People Occupy (Mobility Measure)|Percentage of Eligible Participants Only Observed in a Single Level-16 Bing Tile (no Change in Movement)
Export (.csv)